RE:RE:RE:RE:RE:RE:RE:RE:RE:Momentum forward
Hello Westcoast and I agree way too much negativity. I do have a concern which I have tried to bring up before and would like your thoughts.
You said....We have intellectual property that could well lead to P3 trials and product approvals in two major unmet cancer indications. We can partner with a whole array of other I/O products, for which we can wildly improve their efficacy.
My condern with the IP is that the company is not filing any more patents that we know of and the ones that they have are running out of time. By the time we partner and run a trial and then get hopefull approval it could well take us past the time of our patents. The company desparately needs someone to step up quickly and take the helm and move this along or get a buy out done asap. The longer they wait to see more results the less time they have to set up a trial, get it running , finish it and then with hopeful good result get fda appproval before the patents run out. Think about how long it has taken onc to run any trials. I have tried to bring up this concern before and everyone keeps saying that we will have patent extension upon approval, but the product needs to be approved first and time is our most major factor imo.
Your thoughts are as always appreciated and this is not bashing or being negative, it is simply stating the facts and my concerns in regards to the IP and that is why we really need a buyout to end all speculation with the company IMO of course.